We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current REPH market cap is 219.01M. The company's latest EPS is USD -0.1267 and P/E is -16.50.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21.59M | 24.28M | 21.53M | 21.8M | 23.59M |
| Operating Income | 215k | 613k | -2.6M | -968k | -1.76M |
| Net Income | -3.33M | -9.17M | -4.68M | -3.21M | -4.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 99.22M | 66.5M | 75.36M | 90.21M | 94.64M |
| Operating Income | 25.75M | -8.34M | 412k | 279k | -3.57M |
| Net Income | -18.63M | -27.5M | -11.37M | -19.88M | -13.27M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 151.28M | 157.44M | 149.94M | 148.74M | 151.53M |
| Total Liabilities | 116.05M | 97.58M | 93.96M | 94.42M | 93.27M |
| Total Equity | 35.23M | 59.86M | 55.98M | 54.32M | 58.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 110.46M | 103.42M | 160.32M | 157.44M | 153.47M |
| Total Liabilities | 117.17M | 117.52M | 118.25M | 97.58M | 94.81M |
| Total Equity | -6.71M | -14.1M | 42.06M | 59.86M | 58.66M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.64M | -3.64M | -2.85M | -1.63M | -2.53M |
| Investing | -5.62M | -8.35M | -3.38M | -5.52M | -7.5M |
| Financing | -2.39M | 1.77M | -2.47M | -3.15M | 3.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.5M | 8.07M | 10.86M | -3.64M | -1.01M |
| Investing | -9.86M | -7.6M | -29.29M | -8.35M | -8.24M |
| Financing | 15.99M | 4.15M | 19.89M | 1.77M | 2.34M |
| Market Cap | 219.01M |
| Price to Earnings Ratio | -16.50 |
| Price to Sales Ratio | 2.31 |
| Price to Cash Ratio | 27.04 |
| Price to Book Ratio | 3.73 |
| Dividend Yield | - |
| Shares Outstanding | 104.79M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.11 (5.24%) |
| Company Name | Recro Pharma Inc |
| Address |
1 e. uwchlan ave exton, pennsylvania 19341 |
| Website | https://www.societalcdmo.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
